Cargando…
Midkine and NANOG Have Similar Immunohistochemical Expression Patterns and Contribute Equally to an Adverse Prognosis of Oral Squamous Cell Carcinoma
To increase the overall survival rate and obtain a better prognosis for oral squamous cell carcinoma (OSCC) patients, the detection of more effective and reliable tumor prognostic markers is needed. This study is focused on the analysis of correlation between the clinicopathological features of OSCC...
Autores principales: | Kim, Hyun-Min, Kang, Young-Hoon, Byun, June-Ho, Jang, Si-Jung, Rho, Gyu-Jin, Lee, Jong-Sil, Park, Bong-Wook |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5713308/ https://www.ncbi.nlm.nih.gov/pubmed/29113102 http://dx.doi.org/10.3390/ijms18112339 |
Ejemplares similares
-
Positive expression of NANOG, mutant p53, and CD44 is directly associated with clinicopathological features and poor prognosis of oral squamous cell carcinoma
por: Lee, Hye-Jin, et al.
Publicado: (2015) -
Midkine in Inflammation
por: Weckbach, Ludwig T., et al.
Publicado: (2011) -
Midkine as a prognostic biomarker in oral squamous cell carcinoma
por: Ota, K, et al.
Publicado: (2008) -
Expansile keratocystic odontogenic tumor in the maxilla: immunohistochemical studies and review of literature
por: Byun, June-Ho, et al.
Publicado: (2013) -
Immunohistochemical Expression of Nanog and Its Relation with Clinicopathologic Characteristics in Breast Ductal Carcinoma
por: Saravi, Omid Emadian, et al.
Publicado: (2019)